European Network of Excellence for Big Data in Hematology. Funded by the Innovative Medicines Initiative. Read more
Registration of novel drug compounds is increasingly difficult, costly, and time-consuming, thus preventing patients from receiving the right treatment in time. Patients with hematologic malignancies (HMs) have unmet needs that must be addressed. Read more
51 Partners sharing the same goal: use ‘big data’ technologies to deliver information that will help to improve the care of patients with hematological malignancies: Introducing the HARMONY Alliance. Read more
Europe's largest public-private partnership aiming to improve the outcomes of patients with hematological malignancies through the use of big data sharing among all relevant stakeholders involved.
@HARMONY Talks: Partners, Work Package Leaders and Leaders of the HM Disease Groups are sharing their views and experiences.Read more
Biblioteque Solvay, Brussels, Belgium
March 27, 2018